Breaking News

Axplora to Expand Lyophilization Capabilities at its Le Mans Site

The multi-million-euro investment will strengthen its integrated ADC manufacturing offering.

Author Image

By: Charlie Sternberg

Associate Editor

Axplora, a global CDMO Partner for complex small molecules and antibody-drug conjugates (ADCs), has announced a multi-million-euro investment to expand lyophilization (freeze-drying) capabilities at its Le Mans site, strengthening its ability to deliver reliable, efficient and fast ADC manufacturing for biotech and pharmaceutical customers. Axplora also announced the appointment of François Houbart as Head of Site, Le Mans. The investment directly responds to customer demand for greater contr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters